Stockreport

Keros Therapeutics Announces Participation at Upcoming Healthcare Conferences

Keros Therapeutics, Inc. - common stock  (KROS) 
PDF LEXINGTON, Mass., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focu [Read more]